Mirae Asset Global ETFs Holdings’s Oric Pharmaceuticals ORIC Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$480K	Buy	44,951 +5,763	+15%	+$52.3K	﹤0.01%	2032
2026 Q1	$493K	Sell	39,188 -1,869	-5%	-$21.2K	﹤0.01%	1897
2025 Q4	$335K	Buy	41,057 +9,686	+31%	+$111K	﹤0.01%	2097
2025 Q3	$375K	Buy	31,371 +4,713	+18%	+$49.6K	﹤0.01%	2008
2025 Q2	$271K	Sell	26,658 -13,543	-34%	-$90.9K	﹤0.01%	2121
2025 Q1	$226K	Buy	40,201 +3,131	+8%	+$27.4K	﹤0.01%	2262
2024 Q4	$299K	Buy	37,070 +704	+2%	+$6.46K	﹤0.01%	2173
2024 Q3	$374K	Buy	36,366 +12,467	+52%	+$123K	﹤0.01%	2061
2024 Q2	$168K	Buy	+23,899	New	+$214K	﹤0.01%	2341

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mirae Asset Global ETFs Holdings's ORIC Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Oric Pharmaceuticals (ORIC) stake by 15% in Q2 2026, buying an estimated $52.3K and bringing the position to 44,951 shares worth $480K. The position accounts for ﹤0.01% of the portfolio, ranked #2032.

Mirae Asset Global ETFs Holdings first reported a position in ORIC in Q2 2024 and has held it in 9 quarters since. The position peaked at $493K in Q1 2026. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

Mirae Asset Global ETFs Holdings held 44,951 shares of Oric Pharmaceuticals worth $480K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 5,763 Oric Pharmaceuticals shares in Q2 2026, an estimated $52.3K.
Oric Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2032 holding.
Mirae Asset Global ETFs Holdings first reported a position in Oric Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Oric Pharmaceuticals position peaked at $493K in Q1 2026.
180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.